Safety and immunogenicity of a recombinant nonglycosylated erythrocyte binding antigen 175 Region II malaria vaccine in healthy adults living in an area where malaria is not endemic.

Source:http://linkedlifedata.com/resource/pubmed/id/20702657

Download in:

View as

General Info

PMID
20702657